Nature Communications (Sep 2019)

Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes

  • Dimitrios Evangelopoulos,
  • Gareth A. Prosser,
  • Angela Rodgers,
  • Belinda M. Dagg,
  • Bhagwati Khatri,
  • Mei Mei Ho,
  • Maximiliano G. Gutierrez,
  • Teresa Cortes,
  • Luiz Pedro S. de Carvalho

DOI
https://doi.org/10.1038/s41467-019-12074-z
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 11

Abstract

Read online

D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb.